Bokus

L.R. Overby – författare

Visar alla böcker från författaren L.R. Overby. Handla med fri frakt och snabb leverans.

3 produkter

  1. C.Th. Smit Sibinga, P.C. Das, L.R. Overby - Biotechnology in blood transfusion, Inbunden. Tillgänglighet: Lägg i varukorg

    Biotechnology in blood transfusion

    Proceedings of the Twelfth Annual Symposium on Blood Transfusion, Groningen 1987, organized by the Red Cross Blood Bank Groningen-Drenthe

    Av C.Th. Smit Sibinga, P.C. Das m. fl.

    Inbunden, 1988

    1130 kr

    Lägg i varukorg

    This symposium is devoted to Biotechnology in Blood Transfusion; there are 22 experts discussing the state of the art in the application of monoclonal anti­ bodies, recombinant DNA technologies and heterologous expression systems to the improvement and sometimes replacement of blood products, …

  2. C.Th. Smit Sibinga, P.C. Das, L.R. Overby - Biotechnology in blood transfusion, Häftad. Tillgänglighet: Lägg i varukorg

    Biotechnology in blood transfusion

    Proceedings of the Twelfth Annual Symposium on Blood Transfusion, Groningen 1987, organized by the Red Cross Blood Bank Groningen-Drenthe

    Av C.Th. Smit Sibinga, P.C. Das m. fl.

    Häftad, 2011

    1130 kr

    Lägg i varukorg

    This symposium is devoted to Biotechnology in Blood Transfusion; there are 22 experts discussing the state of the art in the application of monoclonal anti­ bodies, recombinant DNA technologies and heterologous expression systems to the improvement and sometimes replacement of blood products, …

  3. L.R. Overby, P.C. Das, C.Th. Smit Sibinga - Biotechnology in blood transfusion, E-bok. Tillgänglighet: Lägg i varukorg

    Biotechnology in blood transfusion

    Proceedings of the Twelfth Annual Symposium on Blood Transfusion, Groningen 1987, organized by the Red Cross Blood Bank Groningen-Drenthe

    Av L.R. Overby, P.C. Das m. fl.

    E-bok, 2012

    1502 kr

    Lägg i varukorg

    This symposium is devoted to Biotechnology in Blood Transfusion; there are 22 experts discussing the state of the art in the application of monoclonal anti­ bodies, recombinant DNA technologies and heterologous expression systems to the improvement and sometimes replacement of blood products, …